Wordt geladen...
Impact of orphan drugs on Latvian budget
BACKGROUND: Number of orphan medicinal products on the market and number of rare disease patients, taking these usually expensive products, are increasing. As a result, budget impact of orphan drugs is growing. This factor, along with the cost-effectiveness of orphan drugs, is often considered in th...
Bewaard in:
| Gepubliceerd in: | Orphanet J Rare Dis |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864910/ https://ncbi.nlm.nih.gov/pubmed/27169704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-016-0434-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|